Next-Generation Metabolic Research
Retatrutide / RT Series
Eight investigational research-reference specifications with lot and analytical review before supply.
RT Series Specifications
All listed Retatrutide SKUs.
Compare the listed vial strengths and pack formats. Final availability and lot documents are confirmed during technical review.
| SKU | Vial strength | Pack format | Supply scope |
|---|---|---|---|
| RT5Retatrutide | 5 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT10Retatrutide | 10 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT15Retatrutide | 15 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT20Retatrutide | 20 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT30Retatrutide | 30 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT40Retatrutide | 40 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT50Retatrutide | 50 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
| RT60Retatrutide | 60 mg/vial | 10 vials/kit | Lyophilized vial / bulk custom |
Compound-Level Reference
Shared technical identity
Vial strength changes the presentation specification. Compound identity and final lot results remain controlled by the selected batch documents.
- CAS / identity
- Form-specific; confirm selected reference and lot
- Molecular formula
- C221H342N46O68 (PubChem reference record)
- Purity program
- Target ≥98% by HPLC; lot result on COA
- Analytical package
- Lot COA, HPLC chromatogram, LC-MS identity review
B2B Technical Review